Skip to content

TO KNOW THE AMOUNT OF CANINE MOVEMENT AFTER LOCAL INJECTION OF INJECTIBLE PLATELET RICH FIBRIN.

Efficacy of Injectable Platelet Rich Fibrin on the rate of Canine distalization: A split mouth study. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065362
Enrollment
10
Registered
2024-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: K03- Other diseases of hard tissues ofteeth

Interventions

Intervention1: INJECTABLE PLATELET RICH FIBRIN: Injectable Platelet-Rich Fibrin (PRF) is a biomedical product derived from the patients own blood that is used in various medical and dental procedures

Sponsors

Dr Nikita Navgire
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Class I bimax cases requiring first premolar extraction with absolute anchorage. 2. Class II crowding cases requiring first premolar extraction with absolute anchorage. 3. Class II division 1, camouflage cases requiring first premolar extraction with absolute anchorage.

Exclusion criteria

Exclusion criteria: 1. Patients with bone metabolic and blood disorders. 2. Patients with mental disability. 3. Patients with congenital deformity of Oro-Facial structures. 4. Chronic ulcers in oral cavity. 5. Chronic Periodontitis. 6. Facial asymmetry 7. Patients with systemic or chronic debilitating disease that could interfere with bone remodeling. 8. Patients on long-term systemic corticosteroids, calcium channel blockers, antibiotics, bisphosphonates. Or any other medications that could adversely affect the development of the jaws and teeth and subsequent tooth movement. 9. Patients with craniofacial deformities

Design outcomes

Primary

MeasureTime frame
Acceleration of orthodontic tooth movement and thus reduction in treatment duration.Timepoint: T0- at baseline T1- at 30 days T2- at 60 days T3- at 90 days T4- at 120 days T5- at 150 days T6- at 180 days.

Secondary

MeasureTime frame
ACHIEVING SPACE CLOSURETimepoint: T0- at baseline T1- at 30 days T2- at 60 days T3- at 90 days T4- at 120 days T5- at 150 days T6- at 180 days.

Countries

India

Contacts

Public ContactDr. Nikita Navgire

Rural Dental College

drshubhangimani@gmail.com9822772099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026